US20020082687A1 - Polymer heart valve with helical coaption surface - Google Patents
Polymer heart valve with helical coaption surface Download PDFInfo
- Publication number
- US20020082687A1 US20020082687A1 US09/746,379 US74637900A US2002082687A1 US 20020082687 A1 US20020082687 A1 US 20020082687A1 US 74637900 A US74637900 A US 74637900A US 2002082687 A1 US2002082687 A1 US 2002082687A1
- Authority
- US
- United States
- Prior art keywords
- helix
- radius
- leaflets
- valve
- cylinder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
Definitions
- the disclosures herein relate generally to prosthetic heart valves and more particularly to tri-leaflet prosthetic heart valves having polymeric valve leaflets.
- a heart valve prosthesis is implanted into an annular opening in a patient's heart following surgical removal of a diseased or damaged natural valve.
- the valve can be secured in the annulus of the opening through the use of sutures or pins that penetrate the host tissue and an outside edge of the valve.
- the valve can be secured in the annulus by suturing the host tissue to a sewing ring.
- Heart valves function essentially as one-way check valves for blood flow through the beating heart.
- tissue valve refers to bi-leaflet heart valves comprising a valve orifice fabricated at least in part of a rigid, biologically compatible material such as pyrolytic carbon, and comprising essentially no biological components.
- bioprosthetic valve refers to a bi-leaflet or tri-leaflet heart valve comprising at least some biological components such as tissue or tissue components.
- tissue valves are obtained from a donor animal (typically bovine or porcine), and the valve may comprise either biological materials alone or biological materials with man-made supports or stents.
- polymeric valve refers to a tri-leaflet or bi-leaflet heart valve comprising at least some elastomeric polymer components, including at least elastomeric polymer valve leaflets.
- a bi-leaflet mechanical valve typically comprises an annular valve body in which two opposed leaflet occluders are pivotally mounted.
- the occluders are typically rigid, although some designs incorporate semi-rigid leaflets, and the occluders move between a closed position, in which the two leaflets are mated and block blood flow in the reverse direction, and an open position, in which the occluders are pivoted away from each other and do not block blood flow in the forward direction.
- the energy of blood flow causes the occluders to move between their open and closed positions.
- Flexible heart valves seal against reverse flow by having leaflets whose total surface area is greater than the area of the orifice. Sections of the leaflets, therefore, contact one another, or coapt, to close the valve and prevent blood backflow. Coaptive sealing occurs over an area on the leaflets, rather than merely along their edges. Two leaflets are unlikely to seal with any stability if they only contact line to line. This can cause T-boning, or prolapse. T-boning occurs when the end of one leaflet slips below the end of the mating leaflet during closing, forming a line-on-line contact rather than an area contact.
- tissue and polymer valves involve flexible leaflets
- the degree of control possible for the shape of tissue valve leaflets is extremely small, since the leaflets are formed from tissue sheets that are trimmed and sewn to a valve stent.
- Polymer valves may be fabricated by molding, casting, and other known techniques, and therefore allow much greater control of valve body and leaflet shape.
- polymer heart valves may be fabricated with improved wear and performance characteristics.
- leaflets having an analytic shape in a selected position which can be represented generally by analytic geometry.
- An analytic shape may include a portion of a cylindrical surface, of an ellipsoid, of a paraboloid, or of another shape that can be defined mathematically.
- a tri-leaflet heart valve prosthesis typically comprises an annular valve body and three flexible leaflets attached thereto.
- the valve body comprises an annular base and three leaflet support posts.
- a sewing ring annularly coupled to the periphery of the valve body provides a place for sutures to be applied when the valve is implanted.
- the leaflets are attached to the three shaped posts along an attachment curve, and they also each have a free, unattached edge remote from the attachment curve.
- the place where two adjacent leaflets come together at one of the support posts is called the commissure, and the generally curved area on the leaflet between the free edge and the attachment curve is known as the belly of the leaflet.
- the free edges of the three leaflets come together at a “triple point” generally on the axis of the valve.
- U.S. Pat. No. 4,888,009 shows a prosthetic heart valve comprising leaflets of a spherical section, with no additional coaption surface. While this design is simple to fabricate, provides relatively good fabrication control, and has a small gap between leaflets, the vertical component of the angle between the surface tangents of opposed leaflets is not constant. For example, at the triple point and commissures, the leaflet surface tangent is nearly vertical, so the angle between the surface tangents of opposed leaflets is small and an effective and robust seal is facilitated in these regions. However, at the midpoint of the leaflet free edge between the commissures and the triple point, the leaflet surface tangent is much further from vertical.
- the angle between the surface tangents of opposed leaflets is large, and the seal may not be effective or robust. Small deviations in position or load might disrupt the sealing of the leaflets and cause one free margin to slide below the other.
- the leaflets would have a line of contact instead of an area of contact.
- Coaptive surfaces at the ends of the leaflet can be used to prescribe the angle between the surface tangents at the ends of opposing leaflets.
- the simplest shape for a coaptive surface is to have a vertical surface (i.e., a surface oriented generally parallel to the direction of blood flow) at the end of each leaflet. Such surfaces appear to be vertically aligned when the valve is in the closed position.
- two vertical coaption surfaces are actually needed on each leaflet because each leaflet covers 120 degrees (not 180), and the leaflets must bend inward from the commissure to the triple point before again bending back to the other commissure (see FIG. 3).
- Tri-leaflet valves having vertical coaption surfaces therefore, all have three general surface areas: the belly of the leaflet and the two coaptive surfaces.
- Many leaflet belly surface configurations have been proposed (with and without vertical coaption surfaces).
- Tri-leaflet valves having vertical coaption surfaces all suffer from a particular problem. Although the sealing of two vertical surfaces is effective, the discontinuous crease which transitions the coaptive surface to the leaflet belly resists the reverse buckling needed to open the valve. The result is high opening pressures and high pressure drops across the open valve.
- WO 98/32400 provides a valve having leaflets comprising a cylindrical section and having a spherical coaption end. The transition from the leaflet belly to the coaption surface is made by revolving an arc around an axis to form a spherical coaption area.
- the specific shape chosen allows the surface tangencies at the leaflet free edges to be vertical. The designers conclude that bidirectional curvature in the leaflet belly produces poor opening characteristics, and that leaflets with only one degree of curvature in the belly are superior.
- the WO 98/32400 valve provides better performance than a fully spherical leaflet or a fully cylindrical leaflet, the valve has relatively large gaps at the triple point and the commissure.
- Cylindrical leaflets with revolved leaflet end sections e.g. spheres and toroids produce adequate topological solutions for only a limited range of valve heights and gap areas.
- a valve leaflet defined by an analytic shape that provides a smooth transition surface from the leaflet belly to the coaption area, but which avoid large gaps at the commissures and the triple point.
- Analytical shapes suggested in the prior art have not achieved these goals. Therefore, what is needed is a new valve surface topology with more degrees of freedom so that a shorter valve with a small gap area, a cylindrical leaflet, and a tangent coaptive surface can be produced.
- a heart valve with leaflets having a helical swept coaption surface provides advantages not obtained from prior art analytical leaflet shapes.
- the present invention provides a valve leaflet having a base portion geometry comprising a cylindrical section and a top portion geometry comprising a swept helix.
- a heart valve includes a plurality of flexible leaflets. Each leaflet includes a top portion and a bottom portion. The bottom portion is a cylinder having an axis, a radius and an axial section. A first section of the top portion is a surface defined by a first arc having a first radius swept along a first helix.
- the first helix is a right handed helix having the same radius and axis as the cylinder.
- a second section of the top portion is a surface defined by a second arc having a second radius swept along a second helix.
- the second helix is a left handed helix having the same radius and axis as the cylinder.
- a principal advantage of this embodiment is that a leaflet formed by the combination of a base cylinder geometry and a swept helical top geometry provide a valve with improved closure characteristics and which can be made of a small enough size to provide a good fit into the natural anatomy.
- FIG. 1 is a perspective view illustrating an embodiment of a polymer valve in an open position.
- FIG. 2 is a top view of the polymer valve of FIG. 1.
- FIG. 3 is a perspective view illustrating an embodiment of a polymer valve in a closed position.
- FIG. 4 is a top view of the polymer valve of FIG. 3.
- FIG. 5 is a perspective view illustrating an embodiment of a partial valve body and a single leaflet.
- FIGS. 6 - 11 are perspective views illustrating a method of forming the leaflet of FIG. 5.
- a tri-leaflet heart valve prosthesis 10 comprises an annular, generally cylindrical elastomeric valve body 12 and three flexible leaflets 14 made of a biocompatible polymer such as silicone or polyurethane, as shown in FIG. 1. Each leaflet has an attachment edge by which it is coupled to the valve body along an attachment curve 16 . Each leaflet has a free edge 18 that is not coupled to the valve body.
- a sewing ring 20 may be coupled to the base of the valve body 12 to provide a place for sutures to be applied when the valve is implanted.
- the valve body 12 comprises an annular base 22 and a leaflet support, comprising three shaped posts 24 , that support the leaflets 14 .
- each leaflet When fluid flow is in the reverse direction, i.e. in the direction of the arrow R shown in FIG. 3, the pressure of the blood flow causes the leaflets 14 to deflect toward axis 26 , as shown in FIGS. 3 and 4. In this “closed” position, each leaflet would occlude more than one-third of the valve body's orifice were it not for the presence of the other leaflets. Consequently, when the three leaflets deflect toward axis 26 , they engage each other and form coaptive areas along the free edges 18 , which help the valve seal against reverse flow. Further, when the leaflets press together, each leaflet forms a “triple point” 28 at the point where the three leaflets come together, as shown in FIG. 4. The place where the leaflets 14 come together adjacent the posts 24 is called the “commissure” 30 , as shown in FIG. 3.
- Each leaflet 14 of heart valve 10 includes a top portion 32 and a bottom portion 34 , FIG. 5.
- the bottom portion 34 is formed of a surface 36 , see also FIG. 6, defined as a cylinder 38 having an axis 40 , a radius 42 and an axial section 44 .
- a first section A, FIG. 5, of the top portion 32 is a surface defined by a first arc 46 , FIGS. 7 and 10, having a first radius 48 swept along a first helix 50 .
- the first helix 50 is a right-handed helix having the same radius 42 and axis 40 as the cylinder 38 .
- a second portion B, FIG. 5, of the top portion 32 of leaflet 14 is a surface defined by a second arc 52 , FIGS. 8 and 11, having a second radius 54 swept along a second helix 56 .
- the second helix 56 is a left-handed helix having the same radius 42 and axis 40 as the cylinder 38 .
- the first helix 50 has a pitch P, FIG. 9, and the second helix 56 has an equal pitch P. Also, the first radius 48 is equal to the second radius 54 .
- the surface 36 of bottom portion 34 has a curvature C 1 defined by radius 42 .
- each of the first section A and the second section B of the top portion 32 also have the curvature C 1 and a curvature C 2 defined by radii 48 and 54 , respectively, to improve coaption at the free edges 18 .
- Embodiments of the present invention provide leaflets having a smooth surface transition between the bottom portion and top portion thereof.
- the edges of the leaflets are substantially closer to each other when the valve is in the unloaded (“at rest”) position, resulting in a smaller gap between the leaflets.
- the valve has improved closure characteristics.
Abstract
Description
- The disclosures herein relate generally to prosthetic heart valves and more particularly to tri-leaflet prosthetic heart valves having polymeric valve leaflets.
- Prosthetic heart valves for human patients have been available since the 1950s, following the advent of blood oxygenators, which made open heart surgery possible. Today, there are three general types of prosthetic heart valves, including mechanical valves, tissue valves and polymer valves. A heart valve prosthesis is implanted into an annular opening in a patient's heart following surgical removal of a diseased or damaged natural valve. The valve can be secured in the annulus of the opening through the use of sutures or pins that penetrate the host tissue and an outside edge of the valve. Alternatively, the valve can be secured in the annulus by suturing the host tissue to a sewing ring. Heart valves function essentially as one-way check valves for blood flow through the beating heart.
- The term “mechanical valve” as used herein refers to bi-leaflet heart valves comprising a valve orifice fabricated at least in part of a rigid, biologically compatible material such as pyrolytic carbon, and comprising essentially no biological components. The term “bioprosthetic valve” refers to a bi-leaflet or tri-leaflet heart valve comprising at least some biological components such as tissue or tissue components. The biological components of tissue valves are obtained from a donor animal (typically bovine or porcine), and the valve may comprise either biological materials alone or biological materials with man-made supports or stents. The term “polymeric valve” refers to a tri-leaflet or bi-leaflet heart valve comprising at least some elastomeric polymer components, including at least elastomeric polymer valve leaflets.
- A bi-leaflet mechanical valve typically comprises an annular valve body in which two opposed leaflet occluders are pivotally mounted. The occluders are typically rigid, although some designs incorporate semi-rigid leaflets, and the occluders move between a closed position, in which the two leaflets are mated and block blood flow in the reverse direction, and an open position, in which the occluders are pivoted away from each other and do not block blood flow in the forward direction. The energy of blood flow causes the occluders to move between their open and closed positions.
- Flexible heart valves seal against reverse flow by having leaflets whose total surface area is greater than the area of the orifice. Sections of the leaflets, therefore, contact one another, or coapt, to close the valve and prevent blood backflow. Coaptive sealing occurs over an area on the leaflets, rather than merely along their edges. Two leaflets are unlikely to seal with any stability if they only contact line to line. This can cause T-boning, or prolapse. T-boning occurs when the end of one leaflet slips below the end of the mating leaflet during closing, forming a line-on-line contact rather than an area contact.
- Although both tissue and polymer valves involve flexible leaflets, the degree of control possible for the shape of tissue valve leaflets is extremely small, since the leaflets are formed from tissue sheets that are trimmed and sewn to a valve stent. Polymer valves, on the other hand, may be fabricated by molding, casting, and other known techniques, and therefore allow much greater control of valve body and leaflet shape. By precise control of the leaflet shape, polymer heart valves may be fabricated with improved wear and performance characteristics. In particular, by providing leaflets having an analytic shape in a selected position which can be represented generally by analytic geometry. An analytic shape may include a portion of a cylindrical surface, of an ellipsoid, of a paraboloid, or of another shape that can be defined mathematically.
- A tri-leaflet heart valve prosthesis typically comprises an annular valve body and three flexible leaflets attached thereto. The valve body comprises an annular base and three leaflet support posts. A sewing ring annularly coupled to the periphery of the valve body provides a place for sutures to be applied when the valve is implanted. The leaflets are attached to the three shaped posts along an attachment curve, and they also each have a free, unattached edge remote from the attachment curve. The place where two adjacent leaflets come together at one of the support posts is called the commissure, and the generally curved area on the leaflet between the free edge and the attachment curve is known as the belly of the leaflet. The free edges of the three leaflets come together at a “triple point” generally on the axis of the valve.
- One aspect of the sealing problem for tri-leaflet polymer valves arises from the nature of the valve geometry. As already noted, it is desirable to provide leaflets defined by an analytical shape. Tradeoffs must be made, however, among various possible geometries. In particular, it is desirable to provide a coaption surface that seals efficiently and robustly. Many prior art approaches to the difficult problem of leaflet design have been made.
- U.S. Pat. No. 4,888,009 shows a prosthetic heart valve comprising leaflets of a spherical section, with no additional coaption surface. While this design is simple to fabricate, provides relatively good fabrication control, and has a small gap between leaflets, the vertical component of the angle between the surface tangents of opposed leaflets is not constant. For example, at the triple point and commissures, the leaflet surface tangent is nearly vertical, so the angle between the surface tangents of opposed leaflets is small and an effective and robust seal is facilitated in these regions. However, at the midpoint of the leaflet free edge between the commissures and the triple point, the leaflet surface tangent is much further from vertical. Consequently, the angle between the surface tangents of opposed leaflets is large, and the seal may not be effective or robust. Small deviations in position or load might disrupt the sealing of the leaflets and cause one free margin to slide below the other. The leaflets would have a line of contact instead of an area of contact.
- Coaptive surfaces at the ends of the leaflet can be used to prescribe the angle between the surface tangents at the ends of opposing leaflets. The simplest shape for a coaptive surface is to have a vertical surface (i.e., a surface oriented generally parallel to the direction of blood flow) at the end of each leaflet. Such surfaces appear to be vertically aligned when the valve is in the closed position. For a tri-leaflet valve with identical leaflets, two vertical coaption surfaces are actually needed on each leaflet because each leaflet covers 120 degrees (not 180), and the leaflets must bend inward from the commissure to the triple point before again bending back to the other commissure (see FIG. 3). Tri-leaflet valves having vertical coaption surfaces, therefore, all have three general surface areas: the belly of the leaflet and the two coaptive surfaces. Many leaflet belly surface configurations have been proposed (with and without vertical coaption surfaces). Tri-leaflet valves having vertical coaption surfaces all suffer from a particular problem. Although the sealing of two vertical surfaces is effective, the discontinuous crease which transitions the coaptive surface to the leaflet belly resists the reverse buckling needed to open the valve. The result is high opening pressures and high pressure drops across the open valve.
- In addition to leaflets comprising a single analytical shape, attempts have been made to improve valve performance by fabricating leaflets comprising more than one analytical shape. In this regard, WO 98/32400 provides a valve having leaflets comprising a cylindrical section and having a spherical coaption end. The transition from the leaflet belly to the coaption surface is made by revolving an arc around an axis to form a spherical coaption area. In addition, the specific shape chosen allows the surface tangencies at the leaflet free edges to be vertical. The designers conclude that bidirectional curvature in the leaflet belly produces poor opening characteristics, and that leaflets with only one degree of curvature in the belly are superior. Although the WO 98/32400 valve provides better performance than a fully spherical leaflet or a fully cylindrical leaflet, the valve has relatively large gaps at the triple point and the commissure.
- General engineering experience with tissue and polymer heart valves have established a number of criteria for these valves, including:
- 1) A coaption surface which extends from the triple point to the commissure.
- 2) A coaption surface which is tangent to the belly geometry at its bottom and nearly vertical at its top.
- 3) A simple, singly curved leaflet belly.
- 4) A height short enough to fit into the natural anatomy.
- 5) A small gap area between leaflets to reduce regurgitation.
- Cylindrical leaflets with revolved leaflet end sections e.g. spheres and toroids, produce adequate topological solutions for only a limited range of valve heights and gap areas. Given the limitations of existing leaflet geometries, it is desirable to have a valve leaflet defined by an analytic shape that provides a smooth transition surface from the leaflet belly to the coaption area, but which avoid large gaps at the commissures and the triple point. Analytical shapes suggested in the prior art have not achieved these goals. Therefore, what is needed is a new valve surface topology with more degrees of freedom so that a shorter valve with a small gap area, a cylindrical leaflet, and a tangent coaptive surface can be produced.
- It has been discovered that a heart valve with leaflets having a helical swept coaption surface provides advantages not obtained from prior art analytical leaflet shapes. In one embodiment, accordingly, the present invention provides a valve leaflet having a base portion geometry comprising a cylindrical section and a top portion geometry comprising a swept helix. To this end, a heart valve includes a plurality of flexible leaflets. Each leaflet includes a top portion and a bottom portion. The bottom portion is a cylinder having an axis, a radius and an axial section. A first section of the top portion is a surface defined by a first arc having a first radius swept along a first helix. The first helix is a right handed helix having the same radius and axis as the cylinder. A second section of the top portion is a surface defined by a second arc having a second radius swept along a second helix. The second helix is a left handed helix having the same radius and axis as the cylinder.
- A principal advantage of this embodiment is that a leaflet formed by the combination of a base cylinder geometry and a swept helical top geometry provide a valve with improved closure characteristics and which can be made of a small enough size to provide a good fit into the natural anatomy.
- FIG. 1 is a perspective view illustrating an embodiment of a polymer valve in an open position.
- FIG. 2 is a top view of the polymer valve of FIG. 1.
- FIG. 3 is a perspective view illustrating an embodiment of a polymer valve in a closed position.
- FIG. 4 is a top view of the polymer valve of FIG. 3.
- FIG. 5 is a perspective view illustrating an embodiment of a partial valve body and a single leaflet.
- FIGS.6-11 are perspective views illustrating a method of forming the leaflet of FIG. 5.
- A tri-leaflet
heart valve prosthesis 10 comprises an annular, generally cylindricalelastomeric valve body 12 and threeflexible leaflets 14 made of a biocompatible polymer such as silicone or polyurethane, as shown in FIG. 1. Each leaflet has an attachment edge by which it is coupled to the valve body along anattachment curve 16. Each leaflet has afree edge 18 that is not coupled to the valve body. Asewing ring 20 may be coupled to the base of thevalve body 12 to provide a place for sutures to be applied when the valve is implanted. Thevalve body 12 comprises anannular base 22 and a leaflet support, comprising three shapedposts 24, that support theleaflets 14. - When fluid flow is in the forward direction, i.e. in the direction of the arrow F shown in FIG. 1, the pressure of the blood flow causes the
leaflets 14 to deflect away from a centrallongitudinal axis 26 of the valve body that is generally parallel to the threeposts 24. In this “open” position, theleaflets 14 define a large flow orifice, as shown in FIGS. 1 and 2. With the leaflets in the open position, the valve presents little resistance to fluid flow. - When fluid flow is in the reverse direction, i.e. in the direction of the arrow R shown in FIG. 3, the pressure of the blood flow causes the
leaflets 14 to deflect towardaxis 26, as shown in FIGS. 3 and 4. In this “closed” position, each leaflet would occlude more than one-third of the valve body's orifice were it not for the presence of the other leaflets. Consequently, when the three leaflets deflect towardaxis 26, they engage each other and form coaptive areas along thefree edges 18, which help the valve seal against reverse flow. Further, when the leaflets press together, each leaflet forms a “triple point” 28 at the point where the three leaflets come together, as shown in FIG. 4. The place where theleaflets 14 come together adjacent theposts 24 is called the “commissure” 30, as shown in FIG. 3. - Each
leaflet 14 ofheart valve 10 includes atop portion 32 and abottom portion 34, FIG. 5. Thebottom portion 34 is formed of asurface 36, see also FIG. 6, defined as acylinder 38 having anaxis 40, aradius 42 and anaxial section 44. A first section A, FIG. 5, of thetop portion 32 is a surface defined by afirst arc 46, FIGS. 7 and 10, having afirst radius 48 swept along afirst helix 50. Thefirst helix 50 is a right-handed helix having thesame radius 42 andaxis 40 as thecylinder 38. A second portion B, FIG. 5, of thetop portion 32 ofleaflet 14 is a surface defined by asecond arc 52, FIGS. 8 and 11, having asecond radius 54 swept along asecond helix 56. Thesecond helix 56 is a left-handed helix having thesame radius 42 andaxis 40 as thecylinder 38. - The
first helix 50 has a pitch P, FIG. 9, and thesecond helix 56 has an equal pitch P. Also, thefirst radius 48 is equal to thesecond radius 54. As a result of this construction, thesurface 36 ofbottom portion 34 has a curvature C1 defined byradius 42. However, each of the first section A and the second section B of thetop portion 32 also have the curvature C1 and a curvature C2 defined byradii - Embodiments of the present invention provide leaflets having a smooth surface transition between the bottom portion and top portion thereof. In addition, the edges of the leaflets are substantially closer to each other when the valve is in the unloaded (“at rest”) position, resulting in a smaller gap between the leaflets. The valve has improved closure characteristics.
- Although illustrative embodiments have been shown and described, a wide range of modification change and substitution is contemplated in the foregoing disclosure and in some instances, some features of the embodiments may be employed without a corresponding use of other features. Accordingly, it is appropriate that the appended claims be construed broadly and in a manner consistent with the scope of the embodiments disclosed herein.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/746,379 US6454798B1 (en) | 2000-12-21 | 2000-12-21 | Polymer heart valve with helical coaption surface |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/746,379 US6454798B1 (en) | 2000-12-21 | 2000-12-21 | Polymer heart valve with helical coaption surface |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020082687A1 true US20020082687A1 (en) | 2002-06-27 |
US6454798B1 US6454798B1 (en) | 2002-09-24 |
Family
ID=25000584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/746,379 Expired - Lifetime US6454798B1 (en) | 2000-12-21 | 2000-12-21 | Polymer heart valve with helical coaption surface |
Country Status (1)
Country | Link |
---|---|
US (1) | US6454798B1 (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060241744A1 (en) * | 2003-03-20 | 2006-10-26 | Aortech International Plc | Valve |
WO2007137498A1 (en) * | 2006-05-18 | 2007-12-06 | Chang-An Chou | non-invasive vital sign monitoring apparatus and system |
US20100114300A1 (en) * | 2004-12-01 | 2010-05-06 | Cook Incorporated | Medical device with leak path |
GB2488530A (en) * | 2011-02-18 | 2012-09-05 | David J Wheatley | Heart valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US9398952B2 (en) | 2012-12-19 | 2016-07-26 | W. L. Gore & Associates, Inc. | Planar zone in prosthetic heart valve leaflet |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US10321986B2 (en) | 2012-12-19 | 2019-06-18 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic heart valve |
US10376360B2 (en) | 2012-07-27 | 2019-08-13 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic valve apparatus and methods |
US10959842B2 (en) | 2017-09-12 | 2021-03-30 | W. L. Gore & Associates, Inc. | Leaflet frame attachment for prosthetic valves |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US10987218B2 (en) | 2017-10-31 | 2021-04-27 | W. L. Gore & Associates, Inc. | Transcatheter deployment systems and associated methods |
US11020221B2 (en) | 2017-09-27 | 2021-06-01 | W. L. Gore & Associates, Inc. | Prosthetic valve with expandable frame and associated systems and methods |
US11065112B2 (en) | 2014-08-18 | 2021-07-20 | W. L. Gore & Associates, Inc. | Frame with integral sewing cuff for prosthetic valves |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
US11090153B2 (en) | 2017-10-13 | 2021-08-17 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve and delivery system |
US11109963B2 (en) | 2017-09-27 | 2021-09-07 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
US11123183B2 (en) | 2017-10-31 | 2021-09-21 | W. L. Gore & Associates, Inc. | Prosthetic heart valve |
US11154397B2 (en) | 2017-10-31 | 2021-10-26 | W. L. Gore & Associates, Inc. | Jacket for surgical heart valve |
US11439502B2 (en) | 2017-10-31 | 2022-09-13 | W. L. Gore & Associates, Inc. | Medical valve and leaflet promoting tissue ingrowth |
US11471276B2 (en) | 2014-09-15 | 2022-10-18 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562069B2 (en) * | 2001-09-19 | 2003-05-13 | St. Jude Medical, Inc. | Polymer leaflet designs for medical devices |
US20030114924A1 (en) * | 2001-12-18 | 2003-06-19 | Riyad Moe | Polymer heart valve |
US8348963B2 (en) * | 2002-07-03 | 2013-01-08 | Hlt, Inc. | Leaflet reinforcement for regurgitant valves |
US6984243B2 (en) * | 2002-07-30 | 2006-01-10 | Cordis Corporation | Abrasion resistant vascular graft |
CA2714875C (en) * | 2002-08-28 | 2014-01-07 | Heart Leaflet Technologies, Inc. | Method and device for treating diseased valve |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US8449606B2 (en) * | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US8092525B2 (en) * | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US9259317B2 (en) * | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US8216302B2 (en) * | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8778017B2 (en) * | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US8075615B2 (en) * | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US8480730B2 (en) * | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US8597347B2 (en) * | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US8591460B2 (en) * | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
EP2340055B1 (en) | 2008-08-19 | 2017-01-25 | DSM IP Assets B.V. | Implantable valve prosthesis and method for manufacturing such a valve |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
CN105473107B (en) | 2013-06-14 | 2018-05-11 | 心脏解决方案有限公司 | Bicuspid valve spacer and its implant system and method |
WO2015171743A2 (en) | 2014-05-07 | 2015-11-12 | Baylor College Of Medicine | Artificial, flexible valves and methods of fabricating and serially expanding the same |
JP6503454B2 (en) | 2014-05-09 | 2019-04-17 | フォルダックス, インコーポレイテッド | Replacement heart valves and methods of their use and manufacture |
CN114886609A (en) | 2016-10-28 | 2022-08-12 | 福达斯公司 | Prosthetic heart valve with resilient support structure and related methods |
EP3723662A4 (en) | 2017-12-11 | 2021-09-29 | California Institute of Technology | Systems, devices, and methods relating to the manufacture of intravascularly implantable prosthetic valves |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4888009A (en) * | 1985-04-05 | 1989-12-19 | Abiomed, Inc. | Prosthetic heart valve |
GB9701479D0 (en) * | 1997-01-24 | 1997-03-12 | Aortech Europ Ltd | Heart valve |
US6287338B1 (en) * | 1999-03-10 | 2001-09-11 | Sulzer Carbomedics Inc. | Pre-stressing devices incorporating materials subject to stress softening |
-
2000
- 2000-12-21 US US09/746,379 patent/US6454798B1/en not_active Expired - Lifetime
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7988900B2 (en) | 2003-03-20 | 2011-08-02 | Aortech International Plc | Method of making a cardiac valve |
US20060241744A1 (en) * | 2003-03-20 | 2006-10-26 | Aortech International Plc | Valve |
US20100047436A1 (en) * | 2003-03-20 | 2010-02-25 | Aortech International Plc | Method of Making a Cardiac Valve |
US7682389B2 (en) * | 2003-03-20 | 2010-03-23 | Aortech International Plc | Cardiac valve featuring a parabolic function |
US20100114300A1 (en) * | 2004-12-01 | 2010-05-06 | Cook Incorporated | Medical device with leak path |
US20090264714A1 (en) * | 2006-05-18 | 2009-10-22 | Chang-An Chou | Non-invasive vital sign monitoring method, apparatus and system |
WO2007137498A1 (en) * | 2006-05-18 | 2007-12-06 | Chang-An Chou | non-invasive vital sign monitoring apparatus and system |
GB2488530A (en) * | 2011-02-18 | 2012-09-05 | David J Wheatley | Heart valve |
US9259313B2 (en) | 2011-02-18 | 2016-02-16 | David J. Wheatley | Heart valve |
US10285808B2 (en) | 2012-07-25 | 2019-05-14 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US11950999B2 (en) | 2012-07-25 | 2024-04-09 | Edwards Lifesciences Corporation | Everting transcatheter valve and methods |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US11166809B2 (en) | 2012-07-25 | 2021-11-09 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US10376360B2 (en) | 2012-07-27 | 2019-08-13 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic valve apparatus and methods |
US10660745B2 (en) | 2012-12-19 | 2020-05-26 | W. L. Gore & Associates, Inc. | Methods for improved prosthetic heart valve with leaflet shelving |
US10881507B2 (en) | 2012-12-19 | 2021-01-05 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US9827089B2 (en) | 2012-12-19 | 2017-11-28 | W. L. Gore & Associates, Inc. | Methods for improved prosthetic heart valve with leaflet shelving |
US10321986B2 (en) | 2012-12-19 | 2019-06-18 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic heart valve |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US10463478B2 (en) | 2012-12-19 | 2019-11-05 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves |
US10639144B2 (en) | 2012-12-19 | 2020-05-05 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US9398952B2 (en) | 2012-12-19 | 2016-07-26 | W. L. Gore & Associates, Inc. | Planar zone in prosthetic heart valve leaflet |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US11896481B2 (en) | 2012-12-19 | 2024-02-13 | Edwards Lifesciences Corporation | Truncated leaflet for prosthetic heart valves |
US11872122B2 (en) | 2012-12-19 | 2024-01-16 | Edwards Lifesciences Corporation | Methods for improved prosthetic heart valve with leaflet shelving |
US11039917B2 (en) | 2012-12-19 | 2021-06-22 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US11826248B2 (en) | 2012-12-19 | 2023-11-28 | Edwards Lifesciences Corporation | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US11065112B2 (en) | 2014-08-18 | 2021-07-20 | W. L. Gore & Associates, Inc. | Frame with integral sewing cuff for prosthetic valves |
US11471276B2 (en) | 2014-09-15 | 2022-10-18 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
US10959842B2 (en) | 2017-09-12 | 2021-03-30 | W. L. Gore & Associates, Inc. | Leaflet frame attachment for prosthetic valves |
US11020221B2 (en) | 2017-09-27 | 2021-06-01 | W. L. Gore & Associates, Inc. | Prosthetic valve with expandable frame and associated systems and methods |
US11109963B2 (en) | 2017-09-27 | 2021-09-07 | W. L. Gore & Associates, Inc. | Prosthetic valves with mechanically coupled leaflets |
US11857412B2 (en) | 2017-09-27 | 2024-01-02 | Edwards Lifesciences Corporation | Prosthetic valve with expandable frame and associated systems and methods |
US11090153B2 (en) | 2017-10-13 | 2021-08-17 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve and delivery system |
US11439502B2 (en) | 2017-10-31 | 2022-09-13 | W. L. Gore & Associates, Inc. | Medical valve and leaflet promoting tissue ingrowth |
US11154397B2 (en) | 2017-10-31 | 2021-10-26 | W. L. Gore & Associates, Inc. | Jacket for surgical heart valve |
US10987218B2 (en) | 2017-10-31 | 2021-04-27 | W. L. Gore & Associates, Inc. | Transcatheter deployment systems and associated methods |
US11123183B2 (en) | 2017-10-31 | 2021-09-21 | W. L. Gore & Associates, Inc. | Prosthetic heart valve |
US11974916B2 (en) | 2017-10-31 | 2024-05-07 | Edwards Lifesciences Corporation | Jacket for surgical heart valve |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
Also Published As
Publication number | Publication date |
---|---|
US6454798B1 (en) | 2002-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6454798B1 (en) | Polymer heart valve with helical coaption surface | |
US10342661B2 (en) | Prosthetic mitral valve | |
US6174331B1 (en) | Heart valve leaflet with reinforced free margin | |
AU2005204649B2 (en) | Bileaflet prosthetic valve and method of manufacture | |
US8062359B2 (en) | Highly flexible heart valve connecting band | |
US6283995B1 (en) | Heart valve leaflet with scalloped free margin | |
AU727250B2 (en) | Sewing ring having increased annular coaptation | |
EP0732902B1 (en) | Mechanical heart valve with compressible stiffening ring | |
US7455689B2 (en) | Four-leaflet stented mitral heart valve | |
JP2002518131A (en) | A heart valve leaflet coupling structure that changes to affect the location and magnitude of the maximum load pressure on the leaflet | |
CA2671514A1 (en) | Prosthetic heart valve structures and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: SULZER CARBOMEDICS INC., TEXAS Free format text: RELEASE OF SECURITY INTEREST;ASSIGNORS:UBS AG, STAMFORD BRANCH (ON ITS OWN BEHALF AND AS A SECURITY AGENT);CENTERPULSE USA HOLDING CO., A CORP. OF DELAWARE;CENTERPULSE USA INC., A CORP. OF DELAWARE;AND OTHERS;REEL/FRAME:013496/0824 Effective date: 20030121 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: SULZER CARBOMEDICS INC., TEXAS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MOE, RIYAD;REEL/FRAME:019246/0695 Effective date: 20001219 Owner name: CARBOMEDICS INC., TEXAS Free format text: CHANGE OF NAME;ASSIGNOR:SULZER CARBOMEDICS INC.;REEL/FRAME:019246/0812 Effective date: 20030131 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: SORIN GROUP USA, INC., COLORADO Free format text: MERGER;ASSIGNOR:CARBOMEDICS INC.;REEL/FRAME:054944/0546 Effective date: 20091231 Owner name: LIVANOVA USA, INC., COLORADO Free format text: MERGER;ASSIGNOR:LIVANOVA HOLDING USA, INC.;REEL/FRAME:054944/0577 Effective date: 20190628 Owner name: LIVANOVA HOLDING USA, INC., COLORADO Free format text: CHANGE OF NAME;ASSIGNOR:SORIN GROUP USA, INC.;REEL/FRAME:055016/0487 Effective date: 20170630 |
|
AS | Assignment |
Owner name: CORCYM S.R.L., ITALY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LIVANVOA USA, INC.;REEL/FRAME:056544/0121 Effective date: 20210601 |